Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial.
primary studies published RCT
Details- 2015
- Alton EW
A possible alternative exercise test for youths with cystic fibrosis: the steep ramp test.
primary studies published RCT
Details- 2015
- Bongers BC
Use of ibuprofen to assess inflammatory biomarkers in induced sputum: Implications for clinical trials in cystic fibrosis.
primary studies published RCT
Details- 2015
- Chmiel JF
Ciprofloxacin during upper respiratory tract infections to reduce Pseudomonas aeruginosa infection in paediatric cystic fibrosis: a pilot study.
primary studies published RCT
Details- 2015
- Connett GJ
Ciprofloxacin DPI: a randomised, placebo-controlled, phase IIb efficacy and safety study on cystic fibrosis.
primary studies published RCT
Details- 2015
- Dorkin HL
Non-invasive ventilation used as an adjunct to airway clearance treatments improves lung function during an acute exacerbation of cystic fibrosis: a randomised trial.
primary studies published RCT
Details- 2015
- Dwyer TJ
A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patients
primary studies published RCT
Details- 2015
- Elborn JS
Glutamine supplementation in cystic fibrosis: A randomized placebo-controlled trial.
primary studies published RCT
Details- 2015
- Forrester DL
Efficacy response in CF patients treated with ivacaftor: Post-hoc analysis.
primary studies published RCT
Details- 2015
- Konstan MW
Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial.
primary studies published RCT
Details- 2015
- Moss RB